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Summary  26 
We present a unique case of metastatic cholangiocarcinoma with concurrent abdominal 27 
cestodiasis in an African green monkey (Chlorocebus pygerythrus) which presented with 28 
respiratory insufficiency and abdominal discomfort. There were multiple white-grey masses in 29 
the liver and colonic serosa alongside intra-abdominal parasitic cysts. Histopathologically, the 30 
liver masses were composed of poorly-differentiated epithelial cells that formed densely 31 
cellular solid areas and trabeculae. The neoplastic cells were strongly immunopositive for CK7 32 
but negative for Hep-Par1 antigen which confirmed a diagnosis of cholangiocarcinoma. 33 
Interestingly there was strong and diffuse neo-expression in the tumour of the cell cycle 34 
regulator 14-3-3σ which is not constitutively expressed in normal liver. There was aberrantly 35 
strong expression of E-cadherin, a key cell-cell adhesion protein, in neoplastic cells with 36 
evidence of cytoplasmic internalization. This is the first immunohistochemical analysis of 14-37 
3-3σ and E-cadherin in a liver neoplasm in an animal species and the use of these markers 38 
requires further investigation in animal liver tumours.  39 
 40 









The name ´African green monkey´ (AGM) is used by primatologists to designate non-human 50 
primates (NHP) of the genus Chlorocebus which comprises the six species C. sabaeus, C. 51 
aethiops (grivet), C. cynosuros, C. djamdjamensis, C. tantalus and C. pygerythrus (vervet 52 
monkey) (Matz-Rensing and Lowenstine, 2018). Vervets and grivets are among the most 53 
studied NHP and are crucial models in biomedical research. C. pygerythrus is well represented 54 
in most zoological institutions and a significant number are kept in captivity in the main primate 55 
research centres (Jasinka et al., 2013). Vervet monkeys are the best characterized NHP model 56 
of study human immunodeficiency virus infection, neurodegenerative disorders, such as 57 
Alzheimer’s and Parkinson’s diseases, and various endocrine diseases (Jasinka et al., 2013).  58 
 59 
Primary liver neoplasms in NHP are uncommon and only a handful of cases have been reported 60 
including haemangioma, cystadenoma, hepatocellular carcinoma (HCC), hepatic anaplastic 61 
carcinoma, cholangiocarcinoma (CCA) and hepatocholangiolar carcinoma. A literature review 62 
reveals only five CCA in NHP but no record of spontaneous cholangiocarcinoma in a vervet 63 
monkey (Reindel et al., 2000; Miller, 2012; Matz-Rensing and Lowenstine, 2018).  64 
 65 
Risk factors for liver neoplasia in human beings include hepatitis B (HBV) and C (HCV) virus 66 
infections, parasites, chemical carcinogens and other causes of cirrhosis e.g. alcoholic and non-67 
alcoholic steatohepatitis (Razumilava and Gores, 2014; Squadroni et al., 2017). Liver 68 
neoplasms in NHP are most frequently associated with experimental HBV inoculation and 69 
chemical carcinogens including nitrosamines and aflatoxin. No naturally occurring 70 
predisposing causes have been definitively associated with liver neoplasia in NHP (Miller, 71 
2012).  72 
 73 
There is a strong interest in the identification of cell biomarkers of proliferative liver lesions in 74 
human beings. The cell-cycle regulator protein 14-3-3σ has become a very promising human 75 
liver tumour biomarker but, in animal species, has only been investigated in normal canine 76 
liver where it is not constitutively expressed (Suarez-Bonnet et al., 2010; Padden et al., 2014). 77 
E-cadherin, the main cell-adhesion protein, regulates cell-differentiation, maintains cell 78 
structure and its loss is associated with tumour invasiveness, metastasis and a poor prognosis 79 
(Berreta et al., 2017). To date, neither 14-3-3σ nor E-cadherin expression have been 80 
investigated in liver neoplasms in any animal species.  81 
In this report we describe the histopathological and immunohistochemical features of a 82 
metastatic cholangiocarcinoma in a vervet monkey, with a particular focus on 14-3-3σ and E-83 
cadherin expression in the neoplastic cells.  84 
 85 
A 28-year-old, female entire, vervet monkey (Chlorocebus pygerythrus) from a zoological 86 
facility presented with respiratory insufficiency and abdominal discomfort. An exploratory 87 
laparotomy revealed a poorly demarcated white-grey, multilobulated mass replacing 88 
approximately 40% of the liver parenchyma. Parasitic-like, white, translucent, 1 x 1 cm 89 
intraabdominal cysts were also found attached to the greater omentum. Intraoperative 90 
euthanasia was performed on welfare grounds.   91 
 92 
Samples of heart, lung, liver, kidney, uterus, intestine and brain tissues were fixed in 10% 93 
formalin and submitted for histopathological analysis at the Royal Veterinary College. Tissues 94 
were processed routinely, embedded in paraffin-wax, and sections cut (4μm) and stained with 95 
haematoxylin and eosin (HE), Perl’s Prussian blue or by the periodic acid-Schiff (PAS) 96 
method.  97 
 98 
Expanding and effacing liver sections was a well-demarcated, unencapsulated, multilobulated, 99 
infiltrative, densely cellular, malignant epithelial neoplasm. Approximately 90% of neoplastic 100 
cells formed trabeculae and cords that varied from two to eight cells thick and only occasionally 101 
formed densely packed, patternless solid areas. Trabeculae formed multiple large lobules 102 
separated by fine fibrovascular connective tissue septa lined by compressed hepatocytes. 103 
Neoplastic cells were polyhedral, with large amounts of brightly eosinophilic cytoplasm and 104 
contained one or multiple (up to five) large nuclei. Cell nuclei were round to oval with coarsely 105 
clumped chromatin and one or two prominent nucleoli. Anisocytosis, megalocytosis, 106 
anisokaryosis and macrokaryosis were frequent. There were 15 mitoses in 10 x400 fields (2.37 107 
mm2). The boundary between the neoplasm and normal liver tissue was variably outlined by a 108 
rim of lymphocytes and plasma cells (Fig. 1). Unaffected liver parenchyma had multifocal 109 
areas of lymphoplasmacytic pericholangitis, bile duct reduplication and mild portal fibrosis. 110 
The use of Perl´s Prussian blue stain did not reveal excessive iron accumulation. The PAS 111 
method highlighted thin basement membranes supporting neoplastic trabeculae. PAS-positive 112 
secretion was not observed within the neoplasm. Effacing and infiltrating the lung 113 
(Supplementary Fig. 1) and the colonic serosa and muscularis (Supplementary Fig. 2) were 114 
multiple metastatic foci of similar histological appearance. The grossly observed omental cysts 115 
contained cestode larvae that measured 4 x 0.8 mm (Supplementary Fig. 3). They had a ridged 116 
eosinophilic tegument and solid body cavity with numerous calcareous corpuscles. The anterior 117 
end had muscular suckers and within the parenchyma, thin muscles separated the medullary 118 
and cortical regions (Supplementary Fig. 4). Histologically, the parasites were consistent with 119 
Mesocestoides sp. which was confirmed by PCR analysis with amplification of the ITS2 gene 120 
(Crosbie et al., 2000). Additional tissues were histopathologically unremarkable except for 121 
kidney in which tubular loss, fibrosis and mild, multifocal lymphoplasmacytic interstitial 122 
nephritis were considered incidental age-related changes. 123 
 124 
Serial (3μm) sections of liver, colon and lung were immunohistochemically analysed for 125 
expression of cytokeratin (CK) AE1/AE3, CK8/18, CK7, CK20, HepPar1, vimentin, COX-2, 126 
E-Cadherin and 14-3-3σ antigens (Supplementary Table 1). Canine liver (previously used for 127 
antibody optimisation in the authors’ laboratory; Suarez-Bonnet et al., 2010) and NHP kidney 128 
were used as positive controls. As negative controls, primary antibodies were replaced by 129 
homologous non-immune serum (Suarez-Bonnet et al., 2017). Within regions of non-130 
neoplastic primate liver, normal hepatocytes were strongly positive for anti-AE1/AE3, CK 8/18 131 
and Hep-Par1 antigens. Normal biliary epithelium was positive for AE1/AE3, CK7, CK8/18 132 
and negative for Hep-Par1 antigens. Vimentin was expressed only in mesenchymal cells 133 
(including Kupffer cells) in normal and neoplastic liver. In non-neoplastic primate liver, E-134 
cadherin expression was weak and membranous in both hepatocytes and bile ducts. Neoplastic 135 
cells were negative for Hep-Par1 (Fig. 2) but strongly positive for anti-AE1/AE3, CK8/18, 136 
CK7 (Fig. 2; Supplementary Fig. 5). E-Cadherin immunolabelling was positive with both 137 
membrane localization and cytoplasmic internalization of antigen (Fig. 3). Immunolabelling of 138 
14-3-3σ was strong in the cytoplasm and nuclei of neoplastic cells while non-neoplastic 139 
hepatocytes and bile ducts were negative (Fig. 4). COX-2 was variably expressed in hepatocyte 140 
cytoplasm in periportal regions of non-neoplastic liver, corresponding to regions of mild 141 
pericholangitis. Neoplastic cells and bile ducts within non-neoplastic liver were diffusely 142 
negative for COX-2. The histopathological, histochemical and immunohistochemical results 143 
were consistent with a diagnosis of CCA with colonic and lung metastases. 144 
 145 
To the best of our knowledge, this is the first description of 14-3-3σ and E-cadherin expression 146 
in a hepatic neoplasm in an animal species and of spontaneous metastatic cholangiocarcinoma 147 
in a vervet monkey. A single combined hepatocellular-cholangiocellular carcinoma was found 148 
in a survey of 1065 NHP necropsies (Seibold and Wolf, 1973). A case report of a CCA in a 149 
capuchin monkey and rare old reports of cholangiomas in other cercopithecus monkeys lacked 150 
immunohistochemical confirmation or characterisation (Brown et al., 1980).  151 
 152 
Cholangiocarcinoma is an uncommon malignancy, arising from any point in the biliary tree 153 
but characterised by expression of cholangiocyte differentiation markers. The incidence in 154 
human beings varies geographically, presumably reflecting differences in local risk factors and 155 
genetics (Squadroni et al., 2017). In NHP, the relatively few necropsies performed in zoo 156 
facilities is a limiting factor in obtaining an approximate incidence (Matz-Rensing and 157 
Lowenstine, 2018).  158 
 159 
Most human CCA arise de novo, although recently, cirrhosis and HBV and HCV infections 160 
have been recognised as risk factors. The contribution of HBV and HCV in tumour 161 
development differs in western countries, where hepatitis C is more prevalent, compared to 162 
Asian countries, where hepatitis B is endemic. The HBV and HCV status of this monkey is 163 
unknown. Interestingly, chronic lymphoplasmacytic cholangitis with bile duct hyperplasia and 164 
portal fibrosis was present in areas of non-tumoral liver. These changes are similar to those 165 
described in human beings with sclerosing cholangitis (Razumilava and Gores, 2014; 166 
Squadroni et al, 2017). The persistent release of pro-inflammatory cytokines which 167 
accompanies degenerative, necrotic and regenerative changes may have favoured 168 
tumorigenesis in this case (Fava et al., 2007). 169 
 170 
Hepatobiliary trematodiasis has been associated with cholangiocarcinoma and less often with 171 
hepatocellular carcinoma in humans and NHP (Razumilava and Gores, 2014, Squadroni et al., 172 
2017; Díaz-Delgado et al., 2018). Although intraabdominal Mesocestoides sp. were identified 173 
in this case, as cestodes do not follow the same intracanalicular migration route as trematodes, 174 
an association with CCA seems less likely. No other cases of concurrent abdominal 175 
mesocestodiasis and neoplasia have been reported.  176 
 177 
The immunohistochemical profile of this neoplasm is similar to that reported for human CCA 178 
(Berreta et al., 2017). However, our results vary slightly from previous reports in NHP. Reindel 179 
et al. (2000) and Laing et al. (2013) described cases of HCC that expressed both CK7 and 180 
CK8/18. In normal liver, CK7 is restricted to biliary epithelium and thus liver tumours 181 
expressing CK7 are probably cholangiocarcinomas unless they also express Hep-Par1, in 182 
which case a diagnosis of HCC would be more appropriate (Porter et al., 2004). Our case was 183 
diffusely positive for CK7 and CK8/18 but negative for Hep-Par1, which confirms the 184 
diagnosis of cholangiocarcinoma. It is likely that the HCC reported by Reindel et al. (2000) 185 
and Laing et al. (2013) were in fact CCA or combined hepatocellular-cholangiocellular 186 
carcinoma.  187 
 188 
E-Cadherin is a cell-surface protein that has a prominent role in cell-cell adhesion and a well-189 
established tumour suppressor function. The protein is normally expressed on the cell 190 
membrane with loss from that location frequent in CCA (Vaquero et al., 2017). Loss of E-191 
cadherin expression from the cell membrane is often accompanied by its detection within the 192 
cytoplasm which can even be aberrantly upregulated (Jones et al. 2020). Cytoplasmic 193 
internalization and aberrant overexpression were present in this CCA compared with the weak 194 
membranous expression observed in normal bile ducts and hepatocytes. The role of E-cadherin 195 
in tumour progression has been extensively studied. E-cadherin facilitates vascular invasion in 196 
human inflammatory breast cancer in which the chemoresistance of tumour emboli is 197 
associated with the cohesive network provided by E-cadherin overexpression (Rodriguez et al. 198 
2012; Vaquero et al., 2017). Aberrant cytoplasmic E-cadherin expression has also been 199 
observed in neoplastic emboli in canine and equine squamous cell carcinoma (Belluco et al., 200 
2013, Suarez-Bonnet et al., 2018). Additional mechanisms such as promotion of EGFR-201 
mediated PI3K activation leading to pro-survival, pro-migratory AKT signalling and 202 
enhancement of anti-apoptotic proteins Bcl-2 and anoikis resistance of neoplastic cells have 203 
also been reported (Rodriguez et al. 2012).  204 
14-3-3σ is a cell-cycle regulator that functions as either a tumour suppressor or an oncoprotein 205 
in a tumour-dependent manner. Both overexpression, neo-expression and loss have been 206 
reported in a range of neoplasms (Yang et al., 2017). There is neo-expression of 14-3-3σ in 207 
human CCA and HCC which is in agreement with our findings of absence of 14-3-3σ in normal 208 
hepatocytes and bile ducts but strong and homogeneous neo-expression in the CCA. Several 209 
groups recommend the use of 14-3-3σ as a novel and reliable biomarker for liver neoplasia 210 
(Wu et al., 2012; Padden et al., 2014; Reis et al., 2015) but the utility of this marker in NHP 211 
has not previously been explored. Although, the underlying mechanism of action is not well 212 
understood, neoplastic cell migration, invasion and anoikis resistance were reduced in 14-3-3σ 213 
knock-out CCA cell lines, suggesting that this protein could be a promising therapeutic target 214 
(Khongmanee et al., 2013; Yang et al., 2017). Furthermore, 14-3-3σ is normally expressed in 215 
the cytoplasm. When nuclear translocation occurs, as in this case, it is associated with highly 216 
aggressive biological behaviour in carcinomas in other animal species (Suarez-Bonnet et al., 217 
2018).  218 
 219 
Normal human biliary epithelium is COX-2 negative but neoplastic cells in some human CCA 220 
cases have variable expression (Motiño et al., 2016). COX-2 is induced by several transcription 221 
factors and modulated by the balance between oncogenes and tumour suppressor genes. The 222 
negative expression of COX-2 in this neoplasm suggests that it does not play a role in 223 
oncogenesis or that its expression is being suppressed or down-regulated.  224 
 225 
In summary, we have characterized a metastatic CCA with concurrent abdominal 226 
mesocestodiasis, in a species of NHP in which this neoplasm has not been previously reported. 227 
Furthermore, the expression of 14-3-3σ and E-cadherin in this case highlights interesting 228 
comparative features with human CCA. Further investigation of these markers in liver 229 
neoplasms in other animal species is warranted.  230 
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 345 
Figure legends 346 
Fig. 1. Neoplastic cells form thick, short trabeculae and nests (lower left) and have marked 347 
anisocytosis, anisokaryosis and occasional macrokaryosis. Neoplasm is bordered by dense 348 
rim of lymphocytes that blend with non-neoplastic hepatic parenchyma (top right). HE. Bar, 349 
50 μm. 350 
 351 
Fig. 2. Cholangiocarcinoma cells strongly express CK7 antigen as do normal bile ducts (top 352 
right). IHC. Bar, 100 μm. Inset: Non-neoplastic hepatocytes express Hep-Par1 while 353 
cholangiocarcinoma cells are consistently negative (asterisks). IHC. Bar, 50 μm.  354 
 355 
Fig. 3. Neoplastic cells exhibit strong membranous (arrows) and cytoplasmic E-Cadherin 356 
expression. Note bizarre trinucleated cells (arrowheads). IHC. Bar, 100 μm.  357 
 358 
Fig. 4. Neoplastic cells are diffusely and strongly immunopositive for 14-3-3σ. Non-359 
neoplastic hepatocytes are negative (asterisk). IHC. IHC. Bar, 100 μm.  Inset: Strong 360 









Please supply legends for Supplementary figures- add here 370 
 371 
Supplementary Fig. 1. Lung. An extensive area of tumour metastasis infiltrates and effaces 372 
alveolar spaces. HE. Bar, 200 μm.  373 
 374 
Supplementary Fig. 2 Colon. The tunica muscularis is infiltrated and effaced by tumour 375 
metastasis. HE. Bar, 200 μm. 376 
 377 
Supplementary Fig. 3 Mesocestoides sp. larvae (tetrathyridium). HE. Bar, 500 μm. 378 
 379 
Supplementary Fig. 4 Mesocestoides sp. larvae (tetrathyridium). There is an invaginated scolex 380 
with two pairs of suckers (arrows) and calcareous corpuscles (arrowheads) embedded within 381 
the parenchyma. HE. Bar, 50 μm. 382 
 383 
Supplementary Fig. 5 Cholangiocarcinoma cells strongly express CK7 antigen as do normal 384 
bile ducts (arrows). IHC. Bar, 100 μm. 385 
 386 
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